See today's BioWorld
To read the full story, subscribe or sign in.

Adolor Suffers Setback On FDA Request For More Entereg Data

Nov. 7, 2006
By Aaron Lorenzo
The FDA delayed approving Adolor Corp.'s Entereg (alvimopan) for postoperative ileus yet again, pending additional safety data, causing the company's shares to tumble by 44.8 percent on Monday. (BioWorld Today)
BioWorld